Richtlinien zur Einreichung von Proben
What Is AI-Assisted Multi-Omics Data Integration
Multi-omics data integration combines two or more molecular data layers, such as genomics, transcriptomics, epigenomics, proteomics, and metabolomics, from the same or comparable samples into a unified analytical framework. Rather than interpreting each omics layer in isolation, integrative analysis captures how molecular layers relate to one another, revealing regulatory relationships, disease subtypes, and candidate biomarkers that single-omics studies routinely miss.
Why Integration Requires AI-Assisted Methods
Combining omics layers is a high-dimensional, heterogeneous data problem: sample sizes are often small relative to feature counts, platforms differ in scale and noise structure, and missing values are common across layers.
- Heterogeneity: Each omics layer has its own distribution, dynamic range, and technical noise profile, so naive concatenation of raw values can obscure true biology.
- High dimensionality: Feature counts routinely exceed sample counts, which is why our workflows apply dimensionality reduction, regularization, and nested cross-validation before drawing conclusions.
Note: We apply machine learning and statistical modeling as a tool within a study-design-driven analysis, not as a substitute for adequate sample size or replication.
Vertical integration combines omics layers within the same samples; horizontal integration combines the same omics layer across cohorts or studies.
Supported Omics Layers and Data Inputs
- Accepted input: FASTQ, BAM, or annotated VCF from WGS, WES, or panel sequencing
- Used for: variant burden, structural context, and germline background for other omics layers
- Accepted input: bulk or single-cell RNA-seq FASTQ/BAM, or processed count/expression matrices
- Used for: pathway activity, regulatory inference, and cross-omics correlation with proteomics
- Accepted input: WGBS/RRBS methylation calls, ATAC-seq peaks, or ChIP-seq signal tracks
- Used for: regulatory element mapping and methylation-expression correlation
Proteomics & Metabolomics:
- Accepted input: DIA/DDA LC-MS/MS raw files or protein/metabolite quantification matrices
- Used for: functional-layer validation of transcript-level and genomic findings
Microbiome:
16S rRNA amplicon or shotgun metagenomic data can be integrated as an additional layer alongside host omics data for host-microbiome association analysis.
Project Entry Options: Data-to-Insight and Sample-to-Insight
Two ways to start a multi-omics integration project
Data-to-Insight
- You provide existing FASTQ, BAM, VCF, expression matrices, or mass spectrometry data from any combination of omics layers
- We handle QC, harmonization, integration modeling, and interpretation
- Best for labs with data already generated in-house or from a prior sequencing vendor
Sample-to-Insight
- You provide biological samples; qualified partner platforms generate the requested omics data
- Data then flows into the same AI-assisted integration pipeline
- Best for teams that need one coordinated project spanning wet-lab generation and integrative analysis
AI-Assisted Multi-Omics Data Integration Workflow
Our workflow connects data or sample intake, per-layer preprocessing, AI-assisted integration modeling, and interpretation into one project plan, with QC checkpoints at every stage.
Step 1: Project Start
Project discussion to confirm the omics layers involved, the Data-to-Insight or Sample-to-Insight entry option, and the analysis plan.
Step 2: Data / Sample Reception & QC
File format and metadata review for submitted data; sample QC and processing coordination for Sample-to-Insight projects; initial missing-data assessment.
Step 3: Layer-Specific Preprocessing
Per-omics normalization, batch-effect evaluation, and feature filtering carried out separately for each data layer before integration.
Step 4: AI-Assisted Integration & Modeling
Feature alignment across layers, integration modeling using factorization, network-based, or deep learning approaches as appropriate, and nested cross-validation.
Step 5: Interpretation & Delivery
Pathway and network mapping, delivery of the integrated feature matrix and analysis report, and reproducible code.
Choosing the Right Integration Strategy
Different integration methods trade off interpretability, scalability, and sensitivity to missing data. We select and combine strategies based on the omics layers, sample size, and research question rather than defaulting to a single method.
| Integration Strategy | Core Method | Core Advantages | Ideal For |
|---|---|---|---|
| Correlation-Based | Canonical correlation analysis, concatenation-based models | - Simple, interpretable - Fast on small feature sets |
- Two-layer pilot studies - Hypothesis-generating analyses |
| Matrix Factorization | Joint decomposition into shared and layer-specific factors (e.g., MOFA-style models) | - Handles 3+ omics layers - Tolerant of missing samples in one layer |
- Cohort studies with partial layer coverage - Unsupervised subtype discovery |
| Network-Based | Sample similarity networks fused across layers (e.g., similarity network fusion) | - Captures nonlinear cross-layer relationships - Robust to differing data scales |
- Patient stratification - Clustering with heterogeneous omics types |
| Deep Generative / AutoML | Autoencoder-based joint embeddings or automated ensemble model comparison | - Learns complex nonlinear structure - AutoML compares many model families to find the best fit |
- Larger cohorts - Classification or biomarker-panel discovery projects |
Validation and Quality Control
Integrative multi-omics results are only as trustworthy as the validation behind them. Every project includes explicit checks for the failure modes most common in cross-omics modeling.
- Batch and platform effects: Evaluated per omics layer before integration; corrected only when confounding with the outcome is ruled out
- Data leakage and overfitting: Nested cross-validation with strict train/test separation; feature selection performed only within training folds
- Missing data and external validation: Documented imputation strategy per layer; independent cohort or hold-out validation where sample size allows
Applications of Multi-Omics Data Integration in Research
Integrated multi-omics analysis supports a wide range of research questions across disease biology, agriculture, and translational research programs.
Identify candidate multi-layer signatures that separate research groups more reliably than any single omics layer alone.
Molecular Subtyping and Patient Stratification
Cluster samples by integrated molecular profile to reveal subtypes not visible from a single data layer.
Regulatory Mechanism Studies
Link epigenomic and transcriptomic changes to downstream protein and metabolite shifts to build mechanistic hypotheses.
Single-Cell Multi-Omics Integration
Combine single-cell transcriptomic data with other cell-resolved layers to resolve cell-state-specific regulatory programs.
Host-Microbiome Interaction Research
Correlate host transcriptomic or metabolomic shifts with microbiome composition and function.
Deliverables
- Per-layer QC and preprocessing report
- Integrated multi-omics feature matrix and cross-layer correlation network
- Integration model outputs (factor scores, cluster assignments, or classification results, depending on strategy selected)
- Pathway and network interpretation summary
- Reproducible analysis code and environment files
- Methods-ready write-up describing the integration approach and validation strategy
Sample and Data Requirements
Minimum requirements vary by omics layer and project design; the table below summarizes typical starting points.
| Omics Layer | Accepted Input | Typical Minimum | Recommended Metadata |
|---|---|---|---|
| Genomics | FASTQ, BAM, or VCF | ≥30× WGS or matched panel/exome coverage | Platform, capture kit, reference build |
| Transcriptomics | FASTQ, BAM, or count matrix | ≥20 million reads/sample (bulk RNA-seq) | Library prep protocol, batch/run ID |
| Epigenomics | FASTQ/BAM or methylation/peak calls | ≥10× coverage (WGBS) or standard ATAC-seq depth | Assay type, tissue/cell source |
| Proteomics / Metabolomics | LC-MS/MS raw files or quantification matrix | Study-dependent; discuss with project manager | Instrument, acquisition mode (DIA/DDA), batch order |
| For sample-based (Sample-to-Insight) projects, minimum input mass or cell counts follow the requirements of the selected wet-lab platform for each omics layer. | |||
Study Design Requirements
- Adequate sample size per group relative to the number of integrated features; small cohorts are best suited to unsupervised or hypothesis-generating integration rather than predictive modeling
- Clearly defined groups, phenotypes, or outcome variables for supervised integration projects
- Matched or comparable samples across omics layers wherever possible; we can advise on feasibility for partially matched cohorts
- Documented batch, processing date, and platform information for every sample and omics layer
- An independent validation cohort or hold-out set, where available, strengthens any predictive claims
Limitations
- Small sample sizes limit the reliability of supervised integration models and increase the risk of overfitting even with cross-validation
- Class imbalance between study groups can bias integrated classifiers toward the majority group
- Cross-platform and cross-cohort differences can introduce batch effects that are not fully separable from true biological signal
- Correlation among omics layers does not establish causality; integrative findings support hypothesis generation and should be confirmed with orthogonal validation
Reference
- Baião, Ana R., et al. "A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches." Briefings in Bioinformatics 26.4 (2025): bbaf355. https://doi.org/10.1093/bib/bbaf355
- Vahabi, Nasim, and George Michailidis. "Unsupervised multi-omics data integration methods: a comprehensive review." Frontiers in Genetics 13 (2022): 854752. https://doi.org/10.3389/fgene.2022.854752
- Walsh, Ian, et al. "DOME: recommendations for supervised machine learning validation in biology." Nature Methods 18.10 (2021): 1122-1127. https://doi.org/10.1038/s41592-021-01205-4
- Yu, Ying, et al. "Assessing and mitigating batch effects in large-scale omics studies." Genome Biology 25 (2024): 254. https://doi.org/10.1186/s13059-024-03401-9
Demo Results
Model AUC Comparison Across Integrated Omics Layers (Hong F et al., Int J Mol Sci. 2025)
Precision-Recall Curve: Single-Omics vs. Integrated Multi-Omics Model (Hong F et al., Int J Mol Sci, 2025)
Protein Interaction Network of Integration-Derived Hub Molecules (Hong F et al., Int J Mol Sci, 2025)
References
- Hong F, Chen Q, Luo X, et al. A Multi-Omics Integration Framework with Automated Machine Learning Identifies Peripheral Immune-Coagulation Biomarkers for Schizophrenia Risk Stratification. Int J Mol Sci. 2025;26(15):7640. https://doi.org/10.3390/ijms26157640
AI-Assisted Multi-Omics Data Integration FAQs
1. Do I need matched samples across every omics layer?
Matched samples give the strongest integrative signal, but many methods, particularly matrix factorization approaches, tolerate partial overlap where not every sample has data in every layer. We assess your cohort structure during project planning and recommend the integration strategy that fits your actual data coverage.
2. How small a cohort can still support multi-omics integration?
There is no fixed minimum, but very small cohorts are generally better suited to unsupervised, hypothesis-generating integration (for example, exploratory clustering or correlation analysis) rather than supervised classification, where overfitting risk rises sharply as feature count exceeds sample count.
3. Which integration method will you use for my project?
We select the strategy, correlation-based, matrix factorization, network-based, or deep generative/AutoML, according to the number of omics layers, sample size, missing-data pattern, and whether the goal is exploratory or predictive. This is discussed and agreed during project planning rather than fixed in advance.
4. Can you integrate data I generated with a different sequencing or proteomics vendor?
Yes. Under the Data-to-Insight option we accept processed and raw data files from any platform, provided the file formats and accompanying metadata meet the requirements discussed with your project manager.
5. How do you guard against false-positive findings from high-dimensional integration?
Every supervised analysis uses nested cross-validation with feature selection confined to training folds, explicit batch-effect assessment, and, where feasible, an independent validation set or hold-out cohort before any biomarker or subtype claim is reported.
AI-Assisted Multi-Omics Data Integration Case Study
Customer Publication Highlight
A Multi-Omics Integration Framework with Automated Machine Learning Identifies Peripheral Immune-Coagulation Biomarkers for Schizophrenia Risk Stratification
Journal: International Journal of Molecular Sciences
Impact Factor: 4.9 (2024)
Published: 7 August 2025
Background
Schizophrenia is a heterogeneous psychiatric disorder whose molecular underpinnings are poorly resolved by any single omics layer. This study applied an AI-driven multi-omics integration framework to plasma proteomics, post-translational modification (PTM), and metabolomics data from an open-access cohort, aiming to identify integrated molecular signatures that distinguish schizophrenia cases from controls and to prioritize candidate biomarkers for further validation.
Materials & Methods
Cohort
- 104 individuals
- Plasma samples
- Open-access dataset
Omics Layers
- Plasma proteomics
- Post-translational modifications
- Metabolomics
- 17 machine learning models compared
- Multi-omics integration modeling
- Interpretable feature prioritization
Results
- Integration Improves Classification Performance
- Seven of 17 models achieved AUC values exceeding 0.9000 using the integrated multi-omics feature set.
- LightGBMXT was the top-performing model, reaching AUC 0.9727 (95% CI: 0.8889-1.000).
- The best single-omics model (CNNBiLSTM, proteomics only) reached AUC 0.9636 (95% CI: 0.8636-1.0000), below the integrated result.
- Interpretable Biomarker Prioritization
- Carbamylation at immunoglobulin-constant region sites IGKC_K20 and IGHG1_K8 was identified as a key discriminative feature.
- Oxidation of coagulation factor F10 at residue M8 was identified as a second key discriminative modification.
- Pathway and Network Findings
- Enriched pathways included complement activation, platelet signaling, and gut microbiota-associated metabolism.
- Protein interaction network analysis implicated coagulation factors F2, F10, and PLG, along with complement regulators CFI and C9, as central molecular hubs.
Conclusion
Integrating proteomics, PTM, and metabolomics data with an automated machine learning framework improved classification performance over any single omics layer and surfaced an immune-thrombotic molecular signature linking complement activation, platelet signaling, and coagulation to schizophrenia pathology. The study illustrates how AI-assisted multi-omics integration can move beyond single-layer analysis to prioritize mechanistically coherent, cross-validated candidate biomarkers.
Reference
- Hong, Feitong, et al. "A Multi-Omics Integration Framework with Automated Machine Learning Identifies Peripheral Immune-Coagulation Biomarkers for Schizophrenia Risk Stratification." International Journal of Molecular Sciences 26.15 (2025): 7640. https://doi.org/10.3390/ijms26157640
Related Publications
Here are some publications that have been successfully published using our services or other related services:
High-Fat Diets Fed during Pregnancy Cause Changes to Pancreatic Tissue DNA Methylation and Protein Expression in the Offspring: A Multi-Omics Approach
Journal: International Journal of Molecular Sciences
Year: 2024
Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescence
Journal: Cell Death & Disease
Year: 2024
Disruption of tRNA biogenesis enhances proteostatic resilience, improves later-life health, and promotes longevity
Journal: PLoS Biology
Year: 2024
Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivo
Journal: American Journal of Physiology-Gastrointestinal and Liver Physiology
Year: 2024
Nutrient structure dynamics and microbial communities at the water-sediment interface in an extremely acidic lake in northern Patagonia
Journal: Frontiers in Microbiology
Year: 2024
See more articles published by our clients.
